TRIMAS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRIMAS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.49M | Mar 2, 2026 |
| FY2025 | Sep 30, 2025 | $166.02M | Mar 2, 2026 |
| FY2025 | Jun 30, 2025 | $171.75M | Mar 2, 2026 |
| FY2025 | Mar 31, 2025 | $152.46M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $149.73M | Mar 2, 2026 |
| FY2025 | Sep 30, 2024 | $158.53M | Mar 2, 2026 |
| FY2025 | Jun 30, 2024 | $162.78M | Mar 2, 2026 |
| FY2025 | Mar 31, 2024 | $159.76M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $652.15M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $883.83M | Feb 27, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $645.72M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $630.80M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $652.15M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $883.83M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $857.11M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $769.97M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $723.53M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $705.03M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $656.16M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $794.02M | Feb 28, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $195.21M | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $209.33M | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $213.37M | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $199.83M | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $185.53M | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $202.29M | Feb 27, 2018 |
| FY2017 | Jun 30, 2016 | $203.32M | Feb 27, 2018 |
| FY2017 | Mar 31, 2016 | $202.88M | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $192.76M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $222.19M | Feb 28, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.91M | Mar 2, 2026 |
| FY2025 | Sep 30, 2025 | $34.47M | Mar 2, 2026 |
| FY2025 | Jun 30, 2025 | $37.95M | Mar 2, 2026 |
| FY2025 | Mar 31, 2025 | $32.83M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $22.46M | Mar 2, 2026 |
| FY2025 | Sep 30, 2024 | $35.22M | Mar 2, 2026 |
| FY2025 | Jun 30, 2024 | $34.72M | Mar 2, 2026 |
| FY2025 | Mar 31, 2024 | $37.14M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $153.30M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $208.30M | Feb 27, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.70M | Mar 2, 2026 |
| FY2025 | Sep 30, 2025 | $9.30M | Mar 2, 2026 |
| FY2025 | Jun 30, 2025 | $16.72M | Mar 2, 2026 |
| FY2025 | Mar 31, 2025 | $12.42M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $5.64M | Mar 2, 2026 |
| FY2025 | Sep 30, 2024 | $2.53M | Mar 2, 2026 |
| FY2025 | Jun 30, 2024 | $10.94M | Mar 2, 2026 |
| FY2025 | Mar 31, 2024 | $5.14M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $40.36M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $66.17M | Feb 27, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.30M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $15.17M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $50.66M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $99.06M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $95.09M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($88.29M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $91.22M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $108.81M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $92.72M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($41.93M) | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.31M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $109.65M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $102.46M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $131.19M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $121.97M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $134.48M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $102.53M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $91.21M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $99.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $151.96M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.45M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $63.78M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $88.16M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $72.57M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $134.22M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $127.41M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $75.60M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $129.32M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $120.06M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $80.47M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.32B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.34B | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | $1.31B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.30B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.19B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.19B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.10B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.03B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.05B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $779.49M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $656.88M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $658.71M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $653.17M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $672.79M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $609.63M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $495.22M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $480.07M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $489.18M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $551.93M | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $705.59M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $667.30M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $682.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $651.83M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $630.85M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $584.25M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $697.48M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $620.45M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $544.02M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $499.72M | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $300.28M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $287.06M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $293.91M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $339.81M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $315.49M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $303.97M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $334.64M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $316.65M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $319.39M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $315.08M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.41M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $21.67M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $4.23M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($36.13M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($102.30M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($159.61M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($79.85M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($179.66M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($262.96M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($293.92M) | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.02M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $23.07M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $34.89M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $112.09M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $140.74M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $73.95M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $172.47M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $108.15M | Feb 27, 2020 |
| FY2019 | Dec 31, 2017 | $27.58M | Feb 27, 2020 |
| FY2019 | Dec 31, 2016 | $20.71M | Feb 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $472.79M | Mar 2, 2026 |
| FY2024 | Dec 31, 2024 | $401.50M | Feb 27, 2025 |
| FY2023 | Dec 31, 2023 | $400.00M | Feb 29, 2024 |
| FY2022 | Dec 31, 2022 | $400.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $400.00M | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $350.45M | Feb 25, 2021 |
| FY2019 | Dec 31, 2019 | $300.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2018 | $300.00M | Feb 28, 2019 |
| FY2017 | Dec 31, 2017 | $310.81M | Feb 27, 2018 |
| FY2016 | Dec 31, 2016 | $379.37M | Feb 28, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 2, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 27, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37.63M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 40.57M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 41.20M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 41.72M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 42.84M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 43.18M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 44.56M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 45.53M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 45.72M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 45.52M | Feb 27, 2018 |